GEMTESA vs MYRBETRIQ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Possible drug interaction. GEMTESA and MYRBETRIQ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	GEMTESA	MYRBETRIQ
Rating	New	New
Pharmacy pays	—	~$288.81 /30
Type	RX	RX
Active ingredient	VIBEGRON	MIRABEGRON
Manufacturer	Sumitomo Pharma Am	Apgdi
Dosage forms	Tablet	Powder, extended release, Tablet, extended release
Drug class	—	Beta3-Adrenergic Agonist
Boxed warning	None	None
Half-life	—	about 50 hours
Treats	Overactive Urinary Bladder	Overactive Urinary Bladder, Urge Urinary Incontinence

gemtesa myrbetriq

Rating

New

Pharmacy pays

—

~$288.81 /30

Type

Active ingredient

VIBEGRON

MIRABEGRON

Manufacturer

Sumitomo Pharma Am

Apgdi

Dosage forms

Tablet

Powder, extended release, Tablet, extended release

Drug class

—

Beta3-Adrenergic Agonist

Boxed warning

None

Half-life

—

about 50 hours

Treats

Overactive Urinary Bladder

Overactive Urinary Bladder, Urge Urinary Incontinence

Frequently asked questions

What is the difference between Gemtesa and Myrbetriq?

Gemtesa contains Vibegron, while Myrbetriq contains Mirabegron — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.